Latest AI and machine learning research in parkinson's disease for healthcare professionals.
Alzheimer's Disease and Related Dementias (ADRD) afflict almost 7 million people in the USA alone. The majority of research in ADRD is conducted using post-mortem samples of brain tissue or carefully recruited clinical trial patients. While these resources are excellent, they suffer from lack of sex/gender, and racial/ethnic inclusiveness. Electronic Health Records (EHR) data has the potential to ...
PURPOSE: A debilitating and poorly understood symptom of Parkinson's disease (PD) is freezing of gait (FoG), which increases the risk of falling. Clinical evaluations of FoG, relying on patients' subjective reports and manual examinations by specialists, are unreliable, and most detection methods are influenced by subject-specific factors.
Parkinson's Disease (PD) is a degenerative neurological disorder that impairs motor and non-motor functions, significantly reducing quality of life ...
Accurate diagnosis of Parkinson disease, especially in its early stages, can be a challenging task. The application of machine learning techniques h...
Objective: The objective of this study is to develop and evaluate a systematic approach to optimize Deep Brain Stimulation (DBS) parameters, address...
Wearable sensors offer a non-invasive way to collect physical activity (PA) data, with walking as a key component. Existing models often struggle to...
Deep learning holds tremendous potential in healthcare for uncovering hidden patterns within extensive clinical datasets, aiding in the diagnosis of...
Early and accurate detection of Parkinson's disease (PD) is a crucial diagnostic challenge carrying immense clinical significance, for effective tre...
Recent works in pathological speech analysis have increasingly relied on powerful self-supervised speech representations, leading to promising resul...
Accurate diagnosis of gait impairments is often hindered by subjective or costly assessment methods, with current solutions requiring either expensi...
Parkinsons disease, the fastest growing neurodegenerative disorder globally, has seen a 50 percent increase in cases within just two years. As speec...
Parkinson disease (PD) is a chronic neurological disorder primarily characterized by a deficiency of dopamine in the brain. In recent years, numerous ...
Nanorobots are a promising development in targeted drug delivery and the treatment of neurological disorders, with potential for crossing the blood-...
Cognitive decline in Parkinson's disease (PD) varies widely. While models to predict cognitive progression exist, comparing traditional probabilistic ...
Parkinson's disease (PD), a degenerative disorder of the central nervous system, is commonly diagnosed using functional medical imaging techniques s...
Parkinson's disease (PD) belongs to the class of neurodegenerative disorders that affect the central nervous system. It is usually defined as the gr...
Neural biomarkers that can classify or predict disease are of broad interest to the neurological and psychiatric communities. Such biomarkers can be...
The rapid advancement of medical technology has led to an exponential increase in multi-modal medical data, including imaging, genomics, and electro...
Recently, multimodal electroencephalogram (EEG) learning has shown great promise in disease detection. At the same time, ensuring privacy in clinica...
Cycling has gained global popularity for its health benefits and positive urban impacts. To effectively promote cycling, early studies have extensiv...